

"Specialist tissue-based biomarker analysis for pharmaceutical and biotech drug development"
HistologiX is a GLP and GCP compliant contract research organisation specialising in tissue-based biomarker analysis for pharmaceutical and biotechnology companies worldwide. Operating from Nottingham, the company provides bespoke histology, immunohistochemistry, immunofluorescence and digital pathology services supporting drug development from discovery through clinical trials. The company enables scientists to generate regulatory-compliant tissue data that advances therapeutic development. Researchers benefit from customised assay development, specialist sample processing and quantitative biomarker analysis, helping innovative biotherapeutics and immuno-oncology treatments progress toward regulatory approval and reach patients.


28
Team Members
2005
Founded
Contract Research
Sector
On-Site
Work Environment
A world where innovative therapies reach patients faster through precise, reliable tissue-based biomarker analysis that eliminates regulatory obstacles and accelerates drug approval.
Empowers pharmaceutical and biotechnology innovators to advance therapeutics from discovery to clinical approval by providing GLP and GCP compliant tissue-based biomarker analysis as a trusted extension of client research teams.